Alten, R., Nüßlein, H. G., Mariette, X., Galeazzi, M., Lorenz, H., Cantagrel, A., . . . Le Bars, M. (2017). Baseline autoantibodies preferentially impact abatacept efficacy in patients with rheumatoid arthritis who are biologic naïve: 6-month results from a real-world, international, prospective study. RMD Open.
Citação norma ChicagoAlten, Rieke, et al. "Baseline Autoantibodies Preferentially Impact Abatacept Efficacy in Patients With Rheumatoid Arthritis Who Are Biologic Naïve: 6-month Results From a Real-world, International, Prospective Study." RMD Open 2017.
Citação norma MLAAlten, Rieke, et al. "Baseline Autoantibodies Preferentially Impact Abatacept Efficacy in Patients With Rheumatoid Arthritis Who Are Biologic Naïve: 6-month Results From a Real-world, International, Prospective Study." RMD Open 2017.